The Ureteral Stents Market is experiencing steady expansion as the prevalence of kidney stones, urinary tract obstructions, and other urological disorders continues to increase. Ureteral stents are important medical devices used to maintain urine flow from the kidneys to the bladder when the ureter becomes blocked or narrowed. Their widespread use in minimally invasive urological procedures is creating sustained demand across hospitals, nephrological centers, and ambulatory surgical centers.

According to Market Research Future, the global Ureteral Stents Market was valued at USD 668.0 million in 2025. The market is projected to increase from USD 711.8 million in 2026 to USD 1,259.9 million by 2035, registering a CAGR of 6.55% during the forecast period 2026–2035. This growth reflects increasing procedure volumes, technological innovation, and greater adoption of minimally invasive treatment approaches.

Kidney stone treatment remains a major contributor to market expansion. Market Research Future estimates that kidney stone management represented approximately 56.8% of the market in 2025. The increasing occurrence of nephrolithiasis has increased the need for ureteral drainage before or after procedures such as ureteroscopy and lithotripsy. Aging populations are also supporting demand because older patients experience a greater incidence of conditions requiring urinary drainage.

Product innovation is another important market trend. Double pigtail ureteral stents accounted for approximately 42.1% of market share in 2025 because of their broad clinical applications and reliable positioning. At the same time, biodegradable stents are gaining attention, with this segment projected to expand at a CAGR of 10.75% through 2035. These products can potentially reduce the need for secondary removal procedures.

North America currently leads the market, accounting for roughly 38.5% of revenue. Meanwhile, Asia-Pacific represents the fastest-growing region, with an anticipated CAGR of 8.15% through 2035. Increasing healthcare infrastructure investment in countries such as India and China is expected to create additional opportunities.

Overall, technological advances, rising urological disease prevalence, outpatient procedure growth, and development of biocompatible materials are expected to support the long-term expansion of the Ureteral Stents Market.